Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Longboard Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 51 | 52 | +1 |
| Shares | 15.7M | 16.5M | +867.5K (+5.5%) |
| Value | $87.1M | $99.7M | +$12.6M (+14.5%) |
New holders (7)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jennison Associates LLC | 480,828 | $2.90M | 0.00% |
| Ensign Peak Advisors, Inc | 301,161 | $1.82M | 0.00% |
| Platinum Investment Management Ltd | 127,048 | $766.1K | 0.03% |
| Qube Research & Technologies Ltd | 52,443 | $316.2K | 0.00% |
| Walleye Capital LLC | 39,364 | $237.4K | 0.00% |
| Jacobs Levy Equity Management, Inc | 23,853 | $143.8K | 0.00% |
| ADAR1 Capital Management, LLC | 800 | $4.82K | 0.00% |
Sold out (6)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Prosight Management, LP | 321,154 | $1.79M |
| Woodline Partners LP | 81,279 | $451.9K |
| Moore Capital Management, LP | 45,728 | $254.2K |
| Millennium Management LLC | 17,153 | $95.4K |
| Dorsey Wright & Associates | 3,045 | $16.9K |
| Allspring Global Investments Holdings, LLC | 1,371 | $7.62K |